Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery

International Journal of Pharmaceutics

Volumn 116, Issue 1, 1995, Pages 1-9

  Brannon Peppas, Lisa ^a  

^a Biogel Technology Inc   (United States)

Author keywords

Biodegradable polymer; Controlled release; Microparticle; Nanoparticle

Indexed keywords

ACLARUBICIN; DRUG CARRIER; ESTRADIOL; FLUOROURACIL; GENTAMICIN; INDOMETACIN; NAFARELIN; NANOPARTICLE; NORETHISTERONE; POLYMER; VACCINE;

BIODEGRADATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW;

EID: 0028837083     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(94)00324-X     Document Type: Review

References (42)

1. Drug loaded poly(lactic acid) nanoparticles produced by a reversible salting-out process: purification of an injectable dosage form
2. Determinants of release rate of tetanus vaccine from polyester microspheres
3. Biodegradable poly(DL-lactic acid) formulations in a calcitonin delivery system
4. Controlled release of β-estradiol from biodegradable microparticles within a silicone matrix
5. Design and mathematical analysis of controlled release from microsphere-containing polymeric implants
6. Drug delivery from biodegradable microparticles within degradable and nondegradable films
7. Biodegradable PEO/PLA block copolymers
8. Reduction of immunogenicity and extension of circulating half-life of peptides and proteins
9. Biodegradable microspheres: vaccine delivery system, for oral immunization
10. Biodegradable microspheres as a vaccine delivery system
11. Influence of poly(DL-lactide) nanocapsules on the biliary clearance and enterohepatic circulation of indomethacin in the rabbit
12. Analysis of drug release kinetics from degradable polymeric devices
13. Preparation of poly (D,L) lactide microspheres by emulsion-solvent evaporation, and their clinical applications as a convenient embolic material
14. Biodegradable PEG-coated stealth nanospheres
15. Factors influencing the profiles of TRH release from copoly(dllactic/glycolic acid) microspheres
16. Delivery of antisense oligonucleotides from photopolymerized hydrogels
17. Controlled release of interleukin-2 from biodegradable microspheres
18. Controlled cisplatin delivery system using poly(DL-lactic acid)
19. Dissolution, stability, and morphological properties of conventional and multiphase poly(DL-lactic-co-glycolic acid) microspheres containing water-soluble compounds
20. The conjugation of proteins with polyethylene glycol and other polymers: altering properties of proteins to enhance their therapeutic potential
21. Controlled release of bioactive agents from lactide/glycolide polymers
22. Gentamicin/poly(lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively: I. The case of gentamicin base and gentamicin sulfate in poly(DL-lactic acid) oligomers
23. Gentamycin/poly(lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively: II. The case of gentamicin sulfate in high molecular weight poly(DL-lactic acid) and poly(L-lactic acid)
24. Gentamycin/poly(lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively: III. The case of gentamicin sulfate films prepared from high and low molecular weight poly(DL-lactic acids)
25. Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with DL-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior
26. Biodegradable microparticles as controlled release antigen delivery systems
27. The influence of polymer glass transition temperature and molecular weight on drug release from tablets containing poly(DL-lactic acid)
28. Poly(L-lactide): a long-term degradation study in vivo
29. Controlled delivery of an LHRH analogue from biodegradable injectable microspheres
30. The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery
31. Poly(glycolic acid-co-DL- lactic acid): diffusion or degradation controlled drug delivery
32. Controlled delivery of diphtheria toxoid using biodegradable poly(DL-lactide) microcapsules
33. Controlled delivery of Gd-containing liposomes to lymph nodes: surface modification may enhance MRI contrast properties
34. Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process
35. Bioresorbability and biocompatibility of aliphatic polyesters
36. Lactic acid oligomer microspheres containing an anticancer agent for selective lymphatic delivery: I. In vitro studies
37. Preparation of poly(lactic acid) microspheres containing anti-cancer drugs
38. In vivo biocompatibility studies of medisorb 65/36 DL-lactide/glycolide copolymer microspheres
39. In vitro and in vivo release of poly(DL-lactic acid) microspheres containing neurotensin analogue prepared by novel oil-in-water solvent evaporation method
40. Controlled release of albumin from biodegradable poly(DL-lactide) cylinders
41. Preparation and evaluation in vitro and vivo of copoly(lactic/glycolic) acid microspheres containing norethisterone
42. Preparation, characterization and properties of polylactide (PLA)-poly(ethylene glycol) (PEG) copolymers: a potential drug carrier